Get the Stockscreener App
1.12
0.88%
-0.010
After Hours:
1.12
Organigram Global Inc stock is traded at $1.12, with a volume of 701.87K.
It is down -0.88% in the last 24 hours and down -29.56% over the past month.
Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba.
See More
Previous Close:
$1.13
Open:
$1.15
24h Volume:
701.87K
Relative Volume:
1.01
Market Cap:
$157.67M
Revenue:
$200.55M
Net Income/Loss:
$11.80M
P/E Ratio:
12.89
EPS:
0.0869
Net Cash Flow:
$-26.13M
1W Performance:
+4.67%
1M Performance:
-29.56%
6M Performance:
-24.32%
1Y Performance:
-18.25%
1-Day Range:
$1.12
$1.15
1-Week Range:
$1.04
$1.15
52-Week Range:
$1.04
$2.24
Organigram Global Inc Stock (OGI) Company Profile
Compare OGI vs TAK, HLN, TEVA, ZTS, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OGI
Organigram Global Inc
|
1.12 | 159.08M | 200.55M | 11.80M | -26.13M | 0.0869 |
TAK
Takeda Pharmaceutical Co Adr
|
16.25 | 52.07B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
9.29 | 41.28B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
34.07 | 39.78B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
81.32 | 33.57B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
568.43 | 24.02B | 3.17B | 1.29B | 1.01B | 27.09 |
Organigram Global Inc Stock (OGI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-27-26 | Initiated | Canaccord Genuity | Buy |
| Jul-17-24 | Resumed | Canaccord Genuity | Speculative Buy |
| Apr-15-24 | Upgrade | Alliance Global Partners | Neutral → Buy |
| Jan-13-23 | Upgrade | Stifel | Hold → Buy |
| Jan-12-22 | Upgrade | Canaccord Genuity | Hold → Speculative Buy |
| May-11-21 | Upgrade | CIBC | Sector Underperform → Neutral |
| Apr-14-21 | Downgrade | CIBC | Neutral → Sector Underperform |
| Apr-08-21 | Upgrade | BMO Capital Markets | Underperform → Market Perform |
| Mar-10-21 | Downgrade | BMO Capital Markets | Market Perform → Underperform |
| Jan-13-21 | Downgrade | Alliance Global Partners | Buy → Neutral |
| Jan-13-21 | Downgrade | Canaccord Genuity | Speculative Buy → Hold |
| Jul-07-20 | Initiated | Alliance Global Partners | Buy |
| Jan-15-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jan-13-20 | Initiated | BofA/Merrill | Underperform |
| Jan-09-20 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Nov-12-19 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Nov-05-19 | Initiated | Cantor Fitzgerald | Overweight |
| Oct-11-19 | Upgrade | Jefferies | Hold → Buy |
View All
Organigram Global Inc Stock (OGI) Latest News
Top Lite Strategy (LITS) Competitors 2026 - MarketBeat
OGI Stock Price, Quote & Chart | ORGANIGRAM GLOBAL INC (NASDAQ:OGI) - ChartMill
Organigram CEO sees Germany as launchpad for European expansion - MJBizDaily
Organigram says vape weakness pressures margins - MSN
Organigram: Record Harvests Are The Root Of Market Share Erosion (NASDAQ:OGI) - Seeking Alpha
Buy this cannabis stock for a double, analyst says - Cantech Letter
Weekly Roundup on the Cannabis Sector & Psychedelic Sector - marketexclusive.com
Organigram global Q2 earnings call highlights - MSN
Organigram Global Inc.Common Shares (NQ: OGI - The Chronicle-Journal
Cannabis selloff hits CRON, ACB, CGC, TLRY, OGI as reclassification seen limited - MSN
OrganiGram Holdings Reports Q2 2026 Results: Full Earnings Call Transcript - Sahm
Transcript: OrganiGram Holdings Q2 2026 Earnings Conference Call - Sahm
Organigram & Village Farms Earnings Breakdown - The Dales Report
Organigram global Q2 earnings preview - MSN
Organigram Says Vape Weakness Pressures Margins - Sahm
Organigram Holdings stock (CA68620P1018): Q2 2026 results show revenue drop, raised FY guidance - AD HOC NEWS
Organigram Global Sees FY26 Adjusted Ebitda, Adjusted Gross Margin Exceeding FY25 Performance >OGI - Moomoo
Small caps to watch: Boyd Group shares dive after earnings. Plus, Total Energy Services, AGT Food, Goeasy, Algoma Steel and more - The Globe and Mail
Organigram hits 52-week low after Q2 results - MSN
Organigram Global Inc (OGI) Q2 2026 Earnings Call Highlights: Na - GuruFocus
MSN Money - MSN
Earnings Call Summary | Organigram Global Inc(OGI.CA) Q2 2026 Earnings Conference - Moomoo
Organigram Global Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2026 - marketscreener.com
Organigram Global Inc (OGI) Q2 2026 Earnings Call Highlights: Navigating Challenges and Seizing ... By GuruFocus - Investing.com Canada
Organigram Global Inc. 2026 Q2ResultsEarnings Call Presentation (TSX:OGI:CA) 2026-05-12 - Seeking Alpha
Organigram Global Q2 2026 Earnings Call Transcript - MarketBeat
Organigram Global Inc. Updates Revenue Guidance for the Fiscal Year 2026 - marketscreener.com
Organigram Global Inc. Reports Impairment of Property, Plant and Equipment, Intangible Assets and Goodwill for the Second Quarter Ended March 31, 2026 - marketscreener.com
Organigram Global Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Organigram stock hits 52-week low on Q2 results (OGI:NASDAQ) - Seeking Alpha
Organigram Global : INVESTOR PRESENTATION (dad9ab a7f6d4c8) - marketscreener.com
Cannabis Revenue Decline Pressures Organigram Earnings Despite Germany Expansion (OGI) - Yahoo Finance
Organigram Eyes International Growth with Sanity Group to Offset Q2 Revenue Drop - StratCann
OGI Reports Q2 Financials with Adjusted EBITDA Decline - GuruFocus
Organigram Global Q2 Earnings Call Highlights - MarketBeat
Earnings call transcript: OrganiGram posts Q2 2026 financial misses, stock dips - Investing.com
OrganiGram (OGI) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Finance
Organigram Global Files Q2 2026 Results as Sanity Group Deal Extends European Cannabis Reach - TipRanks
OGI: Operational challenges impacted Q2, but improvements and Sanity integration set up a stronger H2 - TradingView
Organigram Reports Second Quarter Fiscal 2026 Results - Business Wire
OGI Forecasts Strong FY26 Adjusted EBITDA and Low Capital Expend - GuruFocus
OrganiGram: Fiscal Q2 Earnings Snapshot - marketscreener.com
Organigram Global Swings to Q2 Net Loss, Net Revenue Falls; Updates Fiscal 2026 Guidance - marketscreener.com
Organigram (NASDAQ: OGI) buys Sanity Group and lifts 2026 outlook amid hemp risks - Stock Titan
Organigram Global : Press Release (dad9ab a96f5298) - marketscreener.com
Organigram Global Sees FY26 Free Cash Flow About Breakeven >OGI - Moomoo
Earnings Flash (OGI) Organigram Global Inc. Reports Q2 Net Loss $0.9M Vs Net Income of $42.5M in Q2 Fiscal 2025 - marketscreener.com
Organigram Q2 Adjusted EBITDA $0.9M, Down 82% YoY - marketscreener.com
Organigram Q2 Net Revenue $59.8M, Down 9% YoY - marketscreener.com
Press Release: Organigram Reports Second Quarter Fiscal 2026 Results - Moomoo
Organigram Global Inc Stock (OGI) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.92%
4.44%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):